Draft Programme (05 May 2016)

Similar documents
SEA-Immun-105 Distribution: General. WHO South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG)

South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) Meeting Report

Monthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO

Sixth Meeting of the South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG)

Report of the Seventh Meeting SEAR- ITAG

Immunization and Vaccine Development (IVD) SEARO

The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region

Protecting people from Vaccine Preventable Diseases

Expanded Programme on Immunization (EPI)

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)

Progress reports on selected Regional Committee resolutions:

WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210

Expanded Programme on Immunization (EPI)

Immunization and Vaccine Development (IVD) SEARO

3. CONCLUSIONS AND RECOMMENDATIONS

Monthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO

Programmatic Feasibility of Measles Elimination in South East Asia Region

Measles and Rubella Fact Sheet SEAR #

REPORT Of the FIRST SOUTH-EAST ASIA REGIONAL TECHNICAL ADVISORY GROUP ON IMMUNIZATION (SEAR ITAG) MEETING July 2008 Bangkok, Thailand

Expanded Programme on Immunization (EPI)

POLIO ERADICATION AND POST-CERTIFICATION STRATEGY

HIV Drug Resistance Surveillance and Monitoring in the Southeast Asia Region

Regional workshop on surveillance standards for measles, rubella and priority vaccine-preventable diseases

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594

How to present the European Vaccine Action Plan (EVAP)

Table 1: Basic information 2017

Expanded Programme on Immunization (EPI)

Agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 6 8 November 2012 CCV/CICG, Geneva

First South-East Asia Regional Technical Advisory Group on Immunization (SEAR ITAG) Meeting

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093

Agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 1 3 April 2014 CCV/CICG, Geneva

Update on Polio Eradication in the World Health Organization South-East Asia Region, 2013

Reduction of child and maternal mortality in South-East Asia Region WHO-SEARO. UNESCAP Forum, New Delhi: 17 Feb 2012

REGIONAL COMMITTEE Provisional Agenda item 5.3. SEA/RC64/8 Inf. Doc. Jaipur, Rajasthan, India 6 9 September August 2011

Meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization Agenda October 2018 CICG, Geneva, Switzerland Version: 19 October 2018

SOUTH-EAST ASIA ACTION PLAN

SEA-Immun-115 Distribution: General. South-East Asia Regional Certification Commission for Polio Eradication (SEA-RCCPE)

Ministerial Round Table: Accelerating implementation of WHO FCTC in SEAR

Table 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712.

South-East Asia Regional Committee resolution (September 2013, New Delhi)

Ending preventable maternal and child mortality

Polio Eradication in India. Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014

Progress towards achieving Millennium Development Goal 5 in South-East Asia

Draft agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 5-7 April 2011 CCV/CICG, Geneva

Progress reports on selected Regional Committee resolutions

Polio post-certification strategy

Joint National/International Expanded Programme on Immunization and Vaccine Preventable Disease Surveillance Review

Beyond effectiveness: research on vaccines seen as a continuum

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

South-East Asia Regional Certification Commission for Polio Eradication (SEA-RCCPE)

Global Measles and Rubella Update November 2018

Global Overview Polio Partners Group, December Note: Gavi requirements of $122.2 million are not included in this slide

Polio Eradication and Surveillance. December

VPD Update for Week 1, 2018 Data as of 8 January 2018 Immunization and Vaccine Development (IVD) SEARO

Regional Vaccine Policy for South-East Asia Region

Polio eradication. Report of the Sixth Meeting of the South-East Asia Regional Certification Commission (SEA-RCCPE) Kathmandu, November 2013

Report of the Immunization Practices Advisory Committee (IPAC) to SAGE. Dr Christopher Morgan, IPAC Chair October 2015

Selected vaccine introduction status into routine immunization

Global Measles and Rubella Update October 2018

Global Measles and Rubella Update. April 2018

Polio endgame strategy The challenges for Asia Pacific Region

Collaborative procedure for licensing Prequalified vaccines

Health, the SDGs and the role of Universal Health Coverage: next steps in the South-East Asia Region, to reach those being left behind

Summary of findings, decisions and recommendations

Remarkable progress, new horizons and renewed commitment. Ending preventable maternal, newborn and child deaths in South-East Asia Region

INACTIVATED POLIOVIRUS VACCINE

Quantitative Immunization and Vaccines Related Research Advisory Committee (QUIVER) Alan R. Hinman, MD, MPH SAGE meeting October 27, 2009

Objective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch

Polio and routine immunisation Alan Brooks

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO

GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights

Draft Agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 9 11 April 2013 CCV/CICG, Geneva

WHO WHO AIDS 2018 JOIN US AT

Polio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions

Eighth Meeting of the International Certification Commission for Polio Eradication for the South-East Asia Region

INTERNATIONAL CERTIFICATION COMMISSION FOR POLIO ERADICATION IN THE SOUTH-EAST ASIA REGION PLAN OF ACTION

Oral Cancer: Rationale for inclusion in SEA Regional NCD Strategy

25th Meeting of the Technical Advisory Group on Immunization and Vaccine-Preventable Diseases in the Western Pacific Region

FROM VISION TO RESULTS

Current situation and capacity in the South-East Asia Region

GAVI Role in IPV Introductions

Information for Access

Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG)

Report to the. GAVI Alliance Board November 2013

HIV Situation in South-East Asia. HIV unit Department of Communicable Diseases

Message from. Dr Samlee Plianbangchang Regional Director, WHO South-East Asia. At the. Regional Review Meeting on Immunization

WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR THE WESTERN PACIFIC MEETING REPORT

Development of the Polio Eradication and Endgame Strategic plan

Meeting Report June 2018 Manila, Philippines

Report of the Regional Consultation on Measles

Status of Outbreak Vulnerable Countries

Nutrition Profile of the WHO South-East Asia Region

Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV

Global Report to SAGE. Fulfillment of previous recommendations & progress highlights

Global burden and costeffective. tobacco control" Dr Douglas Bettcher Director Prevention of Noncommunicable Diseases World Health Organization

Paradigm shift: from dependency to country ownership Seth Berkley, MD Chief Executive Officer of the GAVI Alliance

All photographs used on the cover page are from WHO sources.

Regional Review on Preparedness for the Switch from topv to bopv in the South-East Asia Region

Transcription:

Innovations in sustainable Draft Programme (05 May 2016) Draft 7 th Meeting of the South-East Asia Region Immunization Technical Advisory Group (SEAR ITAG) 6-10 June 2016, New Delhi (India) Day 1, Monday, 6 June 2016 09:00 17:30 Pre-meeting agenda Review of the progress of implementation of the recommendation of ITAG meeting in 2015 Review of the Expanded Programmes on Immunization in SEAR countries based on the reports submitted by the country NITAGs Update on current status of regional priorities (structured format) Identification of discussion points for the thematic areas covered in 4-day programme, 7-10 June ITAG Members SAGE Chair+2 Members RCCPE Chair NITAG/NCIP chairs/members UNICEF (HQ and ROs) WHO (HQ and SEARO) Day 2, Tuesday, 7 June 2016 1

Opening Session 08.30 09.00 Registration 09.00-10.00 Opening Session, RD s speech, photo etc. WHO Regional Director Introduction of ITAG Members; participants ITAG Chair 10.00-10.30 Tea Break Session 1: Review of progress and achievements since last ITAG Progress on implementation of recommendations from the 6 th Meeting of SEAR ITAG, June 2015 10:30 12:00 Progress of NITAG Establishment in SEAR Review of country EPI by NITAGs a summary WHO SEARO 12:00 12:15 Update on implementation of Global Vaccine Action WHO HQ Plan 12:15-12.30 Validation of MNTE - Indonesia MoH Indonesia 12:30-13:00 13:00 14:00 Lunch Break Session 2: Implementing Vaccine Action Plan 14:00 14:15 SEAR Vaccine Action Plan Summary of challenges WHO SEARO and way forward 14:15 15.00 Efforts to reach every child - addressing inequities in immunization WHO & UNICEF MoH India & MoH Nepal a. Brief introductory remarks/presentation b. Country experiences (2 countries) 15:00 15:15 15:15 15:45 Tea Break 15:45 16:00 Nepal Immunization Act-2016: Key aspects MoH Nepal 16:00 17:00 Innovations to sustainable immunization financing in the context of country transition Panel discussion Using HSS approach to address country priority areas of immunization: Lessons learned & challenges - Bangladesh - Myanmar 17.00-18.00 ITAG closed discussion 19:00 21:00 Reception MoH Bangladesh MoH Myanmar Day 3, Wednesday, 8 June 2016 Session 3 Hepatitis B Situation and way forward 09:00 10:00 Regional Viral Hepatitis Action Plan (20 WHO-SEARO Regional Hepatitis B Situation and Action Plan - way WHO-SEARO forward (20 2

(20 10:00-10:30 Tea Break Session 4 - Polio Eradication and Endgame Strategy Situation Update 10:30 12:15 Regional Update on Polio Eradication and endgame WHO SEARO strategy implementation (20 Global Update (20 WHO HQ IPV and bopv supply situation (15 UNICEF SD Stretching IPV supplies (15 WHO SEARO/HQ Containment of polioviruses as per GAP III an update WHO SEARO (20 (15 12:15-13:15 Lunch Session 5 - Polio Eradication and Endgame Strategy Outbreak response 13:15 15:30 Outbreak response assessment (OBRA) and follow-up actions in Myanmar (20+10 WHO-SEARO & MoH Myanmar Updated national outbreak response plan in DPR Korea MoH DPR Korea (20 Responding to a poliovirus outbreak or event post WHO HQ Polio team switch generic SOPs (20 Specific protocol for response to type 2 poliovirus (30 (10 WHO SEARO/ UNICEF ROSA Preparing a country roadmap for outbreak response postswitch brief orientation (25 All countries 15:30-16:00 Tea-break Session 6 Polio Eradication and Endgame Strategy Transition Planning 16:00 17:15 Post- Polio Eradication Transition Planning Principles and Steps (30 Transition planning progress India (15 Evaluation of SMO network Bangladesh (15 (10 17:15 18:00 Developing action plans for transition of polio assets: Break-out session with 5 countries Bangladesh, India, Indonesia, Myanmar, Nepal 17.15 18.15 ITAG closed discussion WHO HQ WHO India/UNICEF India WHO Bangladesh MoH, WHO, UNICEF 3

Day 4, Thursday, 9 June 2016 Session 7: Accelerating Measles Elimination and Rubella/CRS Control 09:00 10:30 Regional Measles and Rubella update situation, WHO SEAR challenges and way forward (30 Global Measles and Rubella update (20 WHO HQ IVB Re-emergence of measles in Bhutan case study (15 MoH Bhutan Managing measles outbreak in Sri Lanka an MoH Sri Lanka experience (15 (10 10:30 11:00 Tea Break 11:00 11:20 Status of MR surveillance in SEAR and recent actions WHO SEAR to improve sensitivity, including molecular epidemiology (20 11:20 11:30 Initiating sentinel CRS surveillance MoH Maldives 11:30 12:30 Group Work: Closing immunity gaps and All countries (4 goups) strengthening surveillance for measles and rubella 12:30 13:30 Lunch Break 13:30 15:00 Presentations from group work (15 mins presentation + 5 mins discussion for each group) 15:00 15:30 Tea Break Session 8: Strengthening data quality for action 15:30 17:15 Data Quality Improving immunization information, recording & reporting in SEAR (20 WHO SEAR Home based records (10 UNICEF Strengthening weekly AFP and measles case based WHO SEAR data reporting (15 Addressing missed opportunities and planning for new MoH Timor Leste CES methodology (15 Follow up to EPI/VPD Surveillance Review - Sri MoH Sri Lanka Lanka (15 Follow up to EPI/Surveillance review Thailand (15 MoH Thailand (15 17.15 18: 15 ITAG closed discussion 4

Day 5, Friday 10 June 2016 Session 9 - Maternal and Neonatal Tetanus Elimination in SEAR 09:00 09:30 MNTE maintenance plan for SEAR WHO SEAR Session 10 - Strengthening Vaccine Quality and Management 09:30 10:30 Vaccine availability & supply (15 UNICEF SD New NRA Assessment tool and progress made in NRA WHO SEAR strengthening in SEAR: special reference to Bangladesh and Myanmar (20 Vaccine management & assessment (EVM UNICEF ROSA/EAPRO assessment new tool) 15 mins 10:30 11:00 Tea Break AEFI field investigation & Causality Assessment WHO SEAR 11:00 11:45 guidelines Session 11 - New and Under-Utilized Vaccines introduction in SEAR 11:45 12:15 Dengue Vaccine Development (WHO position paper and SAGE Recommendations) Update : sharing experiences on: - IPV/PCV post introduction evaluation 12:15 13:00 - Rotavirus vaccine Introduction - JE Introduction 13:00-13:15 s 13:15-14:15 Lunch Break 14:15 15:30 ITAG Closed discussion 15.30-17.00 ITAG Recommendations and Closing WHO - HQ MoH Bangladesh MoH India MoH Indonesia 5